Journal Citation Reports
Journal Citation Reports (JCR) is a product of Clarivate Analytics and is an authoritative resource for bibliometric and citation analysis. It provides a systematic, objective means to critically evaluate the world's leading scientific journals and their impact and influence in the global research community.
Overview
Journal Citation Reports provides a comprehensive overview of the world's most influential academic journals. It uses a combination of impact factor, immediacy index, and other key metrics to provide a snapshot of the influence and importance of a journal in its field. JCR is used by academic institutions, publishers, and researchers to evaluate and compare journals, and to understand their relative importance in the global research community.
History
The first edition of the Journal Citation Reports was published in 1975 by the Institute for Scientific Information (ISI). It was initially a part of ISI's Science Citation Index (SCI), but later became a separate product. In 2016, Clarivate Analytics acquired the product from Thomson Reuters.
Metrics
Journal Citation Reports uses several metrics to evaluate and rank journals. The most well-known of these is the Impact Factor, which measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Other metrics used by JCR include the Immediacy Index, which measures how quickly articles in a journal are cited, and the Eigenfactor Score, which considers the number of times articles from the journal published in the past five years have been cited in the JCR year.
Criticism
Despite its widespread use, Journal Citation Reports has been criticized for its over-reliance on the Impact Factor. Critics argue that the Impact Factor can be manipulated and does not accurately reflect the quality of individual articles. In response to these criticisms, Clarivate Analytics has introduced additional metrics in JCR, such as the Eigenfactor Score and the 5-Year Impact Factor.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD